Background: Abdominal aortic aneurysm (AAA) has an 80% mortality rate upon rupture, with no pharmacological treatments available to slow its progression. Hydrogen sulfide (H₂S), produced by cystathionine γ-lyase (CSE), has anti-inflammatory and antioxidant properties, but its role in AAA remains unclear.
Methods: We evaluated the impact of sodium thiosulfate (STS), a clinically relevant H₂S donor, in a periadventitial elastase-induced AAA model in normotensive male wild-type and Cse-/- mice. Complementary in vitro studies were conducted on primary human vascular smooth muscle cells (VSMCs) to assess the effects of STS on proliferation, senescence and cytokine-induced apoptosis.
Results: Contrary to expectations, STS dose-dependently aggravate AAA progression by increasing extracellular matrix degradation. Although STS reduces macrophage and lymphocyte infiltration, it enhances neutrophil accumulation, particularly MMP9⁺ neutrophils, and promotes the formation of c-KIT⁺-MPO⁺ pre-neutrophil clusters. Cse-/- mice show reduced neutrophil infiltration and smaller aneurysms, supporting a pathogenic role of endogenous H₂S. STS also impairs VSMC proliferation and induces senescence, blunting compensatory aortic remodeling.
Conclusions: H₂S, delivered via STS, exacerbates AAA progression under normotensive conditions by promoting neutrophil-driven inflammation and impairing VSMC repair. These findings challenge the assumption that H₂S is universally protective in vascular disease and raise caution regarding the therapeutic use of STS in patients at risk for AAA.
Abdominal aortic aneurysm (AAA) is a life-threatening condition where a major blood vessel in the abdomen, called the aorta, becomes weak and bulges. There are currently no medications that can slow down AAA growth, and rupture carries a high risk of death. Hydrogen sulfide (H₂S) is a gas naturally produced in the body, that has shown to protect against cardiovascular diseases. This study investigated whether sodium thiosulfate (STS), a H₂S-releasing compound, could reduce AAA progression in mice. Unexpectedly, STS worsened AAA. Our findings highlight the need for caution when considering STS as a treatment for patients at risk of AAA.
© 2025. The Author(s).